InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.420
-0.040 (-1.63%)
At close: Aug 26, 2026, 4:00 PM EDT
2.423
+0.003 (0.13%)
After-hours: Aug 26, 2026, 7:30 PM EDT
InflaRx Employees
InflaRx had 65 employees as of December 31, 2025. The number of employees decreased by 9 or -12.16% compared to the previous year.
Employees
65
Change (1Y)
-9
Growth (1Y)
-12.16%
Revenue / Employee
n/a
Profits / Employee
-$688,021
Market Cap
356.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 74 | 12 | 18.97% |
| Dec 31, 2023 | 62 | 18 | 40.41% |
| Dec 31, 2022 | 44 | -12 | -20.75% |
| Dec 31, 2021 | 56 | 9 | 18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Invivyd | 122 |
| Orchestra BioMed Holdings | 86 |
| Cartesian Therapeutics | 75 |
| Neumora Therapeutics | 63 |
| Vicore Pharma Holding AB | 40 |
IFRX News
- 6 days ago - InflaRx Announces Participation in September Investor Conferences - GlobeNewsWire
- 20 days ago - InflaRx Earnings release: Q2 2026 - Filings
- 20 days ago - InflaRx files $250M mixed securities shelf - TheFly
- 20 days ago - InflaRx Registration statement: Registration filing - Filings
- 20 days ago - InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones - GlobeNewsWire
- 27 days ago - InflaRx to Report Second Quarter 2026 Results on August 6, 2026 - GlobeNewsWire
- 2 months ago - InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos - GlobeNewsWire
- 3 months ago - InflaRx upgraded to Strong Buy from Outperform at Raymond James - TheFly